Lyudmila Bazhenova

Fase II Dose-Gerandomiseerde Study of Sunvozertinib in Platinum-Pretreated Non-Small Cell Lung Cancer With Epidermal ...

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 oktober 2025

Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2025.1.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 augustus 2025

Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2024.3.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025-04

Behandeling of Pleural Mesothelioma: ASCO Guideline Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 maart 2025

NSCLC met driveralteraties: ASCO Living Guideline versie 2025.1

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 december 2024

NSCLC met driveralteraties: ASCO Living Guideline 2024.1

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 april 2024

NSCLC zonder driveralteraties: ASCO Living Guideline 2024.1

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 10 april 2024

QoL en risicovoorspelling bij nivolumab-ipilimumab versus chemotherapie bij NSCLC: CheckMate 9LA

Journal of the National Cancer Institute · 11 april 2023

Nivolumab plus ipilimumab versus nivolumab bij plaveiselcel-NSCLC: Lung-MAP S1400I

JAMA oncology · 1 september 2021

Cetuximab plus carboplatine-paclitaxel met of zonder bevacizumab versus standaard bij NSCLC: SWOG S0819

The Lancet. Oncology · 2018-01

Publicaties op Oncologisch.com